MSC2

AcronymDefinition
MSC2Multi-Service Command & Control
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
The MSC2 phenotype, with its enhanced anti-inflammatory function, has therapeutic potential against demyelinating disorders (e.g., optic neuritis, multiple sclerosis, and Krabbe disease), diabetic neuropathy, and inflammatory disorders (e.g., rheumatoid arthritis and Crohn's disease).
It was observed in three strains (MSF21, MSF20, MSF19) isolated from Fetzara and two strains (MSC2, MSC9) isolated from Chatt.
The MSC2 multi-speed fan drive is similar to the ECI system in that it uses an eddy current system to operate in the low-speed mode.
Betancourt, "A new mesenchymal stem cell paradigm: polarization into a proinflammatory MSC1 or an immunosuppressive MSC2 phenotype," PloS One, vol.
Assays were done in FBS-containing medium when hMSC were expanded in FBS-Medium or in SCC-containing medium for hMSC expanded in XF-Medium (MSC1: hMSC with immunostimulatory properties; MSC2: hMSC with immunosuppressive properties) (n = 4, Kruskal- Wallis test followed by Dunn's multiple comparison test).
So, for Kondor varieties, MSC1 and MSC2 media cultures were most appropriates (Table 1).
Culture KONDOR SPUNTA mediums stem Stem Induction Percentage Induction Percentage time (%) time (days) (days) MSC -- -- -- -- MSC1 40 67 -- -- MSC2 30 73 -- -- MSC3 -- -- 50 70 MSC4 -- -- 40 77 Culture mediums Leaf Induction Percentage time (days) MSC -- -- MSC1 -- -- MSC2 -- -- MSC3 35 17 MSC4 35 20 Table 2: Results of induction of somatic meristems in Spunta and Kondor varieties.
Betancourt, "Anti-inflammatory mesenchymal stem cells (MSC2) attenuate symptoms of painful diabetic peripheral neuropathy," Stem Cells Translational Medicine, vol.
Transcriptomes of AF-MSC1 and AF- MSC2 cluster with fMSC while those of the H1, H9, and iPSCs cluster separately.
IL-1[alpha], IL-1[beta], IL-6, IL-8, IL-10, IL-11, HGF, TGF-[beta]1, IDO, and LIF gene expression and protein secretion from WJ-MSC1, WJ- MSC2, and WJMSC3.
proposed the idea that the induction of proinflammatory (MSC1) or anti-inflammatory (MSC2) phenotypes of MSCs depends on the ligand concentration, the timing, and the kinetics of activation [175].
[58] to propose a paradigm where, in analogy with monocyte/macrophage M1 and M2, MSCs can act as MSC1 type (proinflammatory) or MSC2 type (immunosuppressive).